Literature DB >> 26772886

miR-1182 inhibits growth and mediates the chemosensitivity of bladder cancer by targeting hTERT.

Jun Zhou1, Wenbin Dai2, Jianming Song3.   

Abstract

microRNAs (miRNAs) have been demonstrated to contribute to tumor progression and metastasis and proposed to be key regulators of diverse biological processes. In this study, we report that miR-1182 is deregulated in bladder cancer tissues and cell lines. To characterize the role of miR-1182 in bladder cancer cells, we performed functional assays. The overexpression of miR-1182 significantly inhibits bladder cancer cell proliferation, colony formation, and invasion. Moreover, its up-regulation induced cell cycle arrest and apoptosis and mediated chemosensitivity to cisplatin in bladder cancer. Furthermore, a luciferase reporter assay and a rescue experiment indicated that miR-1182 directly targets hTERT by binding its 3'UTR. In conclusion, these results demonstrate that miR-1182 acts as a tumor suppressor and may be a potential biomarker for bladder cancer diagnosis and treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Chemosensitivity; hTERT; miR-1182

Mesh:

Substances:

Year:  2016        PMID: 26772886     DOI: 10.1016/j.bbrc.2016.01.014

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.

Authors:  Lei Wang; Yan-Feng Shen; Zhi-Min Shi; Xiao-Juan Shang; Dong-Ling Jin; Feng Xi
Journal:  J Clin Lab Anal       Date:  2017-07-13       Impact factor: 2.352

2.  Vascular Actions of Angiotensin 1-7 in the Human Microcirculation: Novel Role for Telomerase.

Authors:  Matthew J Durand; Natalya S Zinkevich; Michael Riedel; David D Gutterman; Victoria L Nasci; Valerie K Salato; John B Hijjawi; Charles F Reuben; Paula E North; Andreas M Beyer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-14       Impact factor: 8.311

3.  Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.

Authors:  Hui Zhang; Minghui Li; Jing Zhang; Yanbing Shen; Qi Gui
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

Review 4.  The role of microRNAs in bladder cancer.

Authors:  Hideki Enokida; Hirofumi Yoshino; Ryosuke Matsushita; Masayuki Nakagawa
Journal:  Investig Clin Urol       Date:  2016-06-07

5.  MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2.

Authors:  Xin Zhao; Zhigang Ji; Yi Xie; Guanghua Liu; Hanzhong Li
Journal:  Oncol Rep       Date:  2017-09-25       Impact factor: 3.906

6.  Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer.

Authors:  Wujian Zheng; Qi Feng; Jiao Liu; Yanke Guo; Lvfen Gao; Ruiman Li; Meng Xu; Guizhen Yan; Zhinan Yin; Shuai Zhang; Shuangping Liu; Changliang Shan
Journal:  Front Pharmacol       Date:  2017-06-30       Impact factor: 5.810

Review 7.  Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer.

Authors:  Ricardo Leão; Joana Dias Apolónio; Donghyun Lee; Arnaldo Figueiredo; Uri Tabori; Pedro Castelo-Branco
Journal:  J Biomed Sci       Date:  2018-03-12       Impact factor: 8.410

Review 8.  Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs.

Authors:  Bernhard Biersack
Journal:  Noncoding RNA Res       Date:  2016-10-13

9.  miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8.

Authors:  Yao Liu; Bing Zhang; Tiefeng Shi; Huadong Qin
Journal:  Onco Targets Ther       Date:  2017-02-24       Impact factor: 4.147

Review 10.  MicroRNA Regulation of Telomerase Reverse Transcriptase (TERT): Micro Machines Pull Strings of Papier-Mâché Puppets.

Authors:  Ammad Ahmad Farooqi; Qaisar Mansoor; Nada Alaaeddine; Baojun Xu
Journal:  Int J Mol Sci       Date:  2018-04-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.